sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
24-Jul-2016 10:59
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 801-825 out of 1284.

<< < 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>

Public Release: 22-Apr-2015
Lancet Infectious Diseases
Researchers discover never-before-seen tick-borne disease
Just in time for spring and the explosion of ticks in forests, lawns and trails, a new study by researchers from China and the University of Maryland School of Medicine has uncovered a never-before-seen illness transmitted by ticks. The disease could be a 'substantial health threat' to humans and animals in areas where the carrier tick is common.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 22-Apr-2015
Journal of Virus Eradication
Global hepatitis B epidemic can be treated for $36 (£24) per person per year
Scientists at the University of Liverpool have demonstrated that a drug for treating hepatitis B virus could be mass-produced for only £24 ($36) per person per year, versus the current UK NHS price of £4,600, and the US price of over $15,000.

Contact: Sarah Stamper
University of Liverpool

Public Release: 22-Apr-2015
Ebola survivors donate plasma to tackle outbreak
The first donations of plasma, from survivors of the Ebola epidemic in Sierra Leone, have been received by an international research team working to help tackle current and future disease outbreaks in West Africa.
Wellcome Trust

Contact: Sarah Stamper
University of Liverpool

Public Release: 22-Apr-2015
PLOS Biology
Boosting the malaria battle-line
In a huge boost to the global fight against malaria, researchers have discovered how the malaria parasite protects itself by building resistance against the last-line in antimalarial medications, and how a new medical treatment can overcome the parasite's defenses.

Contact: Anne Rahilly
University of Melbourne

Public Release: 22-Apr-2015
Twins experiment reveals genetic link with mosquito bites
The likelihood of being bitten by mosquitoes could be down to our genes, according to a study carried out on twins.
Sir Halley Stewart Trust

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 22-Apr-2015
UTMB researchers develop Ebola treatment effective 3 days after infection
Researchers from The University of Texas Medical Branch at Galveston and Tekmira Pharmaceuticals Corp., have successfully developed a post-exposure treatment that is effective against a specific strain of the Ebola virus that killed thousands of people in West Africa.
National Institutes of Health

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 21-Apr-2015
Book details misconceptions about smallpox's role in Native depopulation
As part of his new book, 'Cherokee Medicine, Colonial Germs: An Indigenous Nation's Fight against Smallpox, 1518-1824,' a University of Kansas history professor disputes the idea that infectious diseases themselves gave Europeans an advantage over Native-Americans because indigenous peoples did not have the right medicine or knowledge base to fight these new diseases, such as smallpox.

Contact: George Diepenbrock
University of Kansas

Public Release: 21-Apr-2015
Immune cells support good gut bacteria in fight against harmful bacteria
The immune cell protein ID2 is critical for the maintenance of healthy gut microbiota, helping good bacteria fight off harmful bacteria. This study, published in Immunity, shows how the immune system shapes the gut microbiota to limit infections.
National Institutes of Health

Contact: Ashley Heher
University of Chicago Medical Center

Public Release: 21-Apr-2015
Fourth Global Forum on TB Vaccines
New research points to elderly as growing contributor to tuberculosis in China
A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next decades, requiring a refocus in efforts to control a disease affecting millions in China, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai. Researchers from the LSHTM found that developing a 'post-infection' vaccine could reduce overall TB rates in China by almost a third by 2050.

Contact: Ellen Wilcox

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Notre Dame researchers detecting low quality antimalarial drugs with a lab-on-paper
Access to high-quality medicine is a basic human right, but over four billion people live in countries where many medications are substandard or fake. Marya Lieberman of the Department of Chemistry and Biochemistry at the University of Notre Dame and Abigail Weaver a postdoctoral associate in the University's Department of Civil Engineering and Environmental and Earth Sciences took up the challenge of how people in developing countries could detect low quality antimalarial drugs without expensive equipment and without handling dangerous chemicals.

Contact: Marya Lieberman
University of Notre Dame

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Global pandemic of fake medicines poses urgent risk, scientists say
Poor quality medicines are an urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and TB, according to the editors of a journal supplement published today. Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples. Seventeen articles are included in the supplement 'The Global Pandemic of Falsified Medicines,' published by The American Journal of Tropical Medicine and Hygiene.
NIH/Fogarty International Center, Bill & Melinda Gates Foundation, New Venture Fund

Contact: Ann Puderbaugh
NIH/Fogarty International Center

Public Release: 20-Apr-2015
American Journal of Tropical Medicine and Hygiene
Fake malaria drugs not as common as previously reported
A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research from the London School of Hygiene & Tropical Medicine.
Bill and Melinda Gates Foundation

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 20-Apr-2015
Proceedings of the National Academy of Sciences
Cancer drug shows promise as cure for hepatitis B
Australian scientists have found a potential cure for hepatitis B virus infections, with a promising new treatment proving 100 percent successful in eliminating the infection in preclinical models. Australian patients are now the first in the world to have access to the potential treatment -- a combination of an antiviral drug and an anti-cancer drug -- which is in phase 1/2a clinical trials in Melbourne, Perth and Adelaide.
National Health and Medical Research Council, Australian Research Council, Victorian Government

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 19-Apr-2015
American Association for Cancer Research Annual Meeting 2015
Broccoli sprout extract promising for head and neck cancer prevention
Broccoli sprout extract protects against oral cancer in mice and proved tolerable in a small group of healthy human volunteers, the University of Pittsburgh Cancer Institute, partner with UPMC CancerCenter, announced today at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
NIH/National Cancer Institute

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 17-Apr-2015
Antimicrobial Agents and Chemotherapy
New genetic mutation could signal start of malaria drug resistance in Africa
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research from the London School of Hygiene & Tropical Medicine.

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 16-Apr-2015
Subsidies key in improving sanitation, new study finds
For years, governments and major development institutions have vigorously debated how to address poor sanitation in developing countries, which causes 280,000 deaths per year worldwide. A new study released in Science today found that in Bangladesh, a community-motivation model that has been used in over 60 countries to increase use of hygienic latrines had no effect, but that latrine coverage expands substantially when that model is combined with subsidies for hygienic latrines targeted to the poor.

Contact: Heidi McAnnally-Linz
Innovations for Poverty Action

Public Release: 16-Apr-2015
PLOS Neglected Tropical Diseases
160 people die of rabies every day, says major new study
A global study on canine rabies, published April 16, 2015, has found that 160 people die every single day from the disease. The report is the first study to consider the impact in terms of deaths and the economic costs of rabies across all countries. Even though the disease is preventable, 59,000 people die every year of rabies transmitted by dogs, and the disease costs global economies $8.6 billion US.
UBS Optimus Foundation, Wellcome Trust

Contact: Kevin Doran
Global Alliance for Rabies Control

Public Release: 15-Apr-2015
Canada, India fund 5 innovations to improve health in India, with focus on mothers and children
Canada and India today announced investments of CDN $2.5 million in five innovations in India aimed primarily at improving maternal, newborn and child health -- Canada's flagship development priority. Canadian government-funded Grand Challenges Canada and the Grand Challenges India initiative of the Government of India, made the joint announcement during the official visit to Canada of India's Prime Minister Narendra Modi.
Grand Challenges Canada, Grand Challenges India

Contact: Lode Roels
Grand Challenges Canada

Public Release: 15-Apr-2015
DNA and Cell Biology
Fighting tuberculosis using the body's natural anti-microbial processes
A new approach to combatting tuberculosis would take advantage of a complex, natural process called autophagy that the human body uses to recycle nutrients, remove damaged cell components, eliminate invading bacteria, and respond to inflammation. In addition to its potential as a novel therapeutic strategy, autophagy is the focus of increasing research to understand the role it may have in a range of diseases including heart disease, diabetes, and age-related neurodegenerative disorders such as Alzheimer's disease.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 14-Apr-2015
The Journal of Alternative and Complementary Medicine
Antimalarial tea -- from herbal remedy to licensed phytomedicine
Malaria is a critical health problem in West Africa, where traditional medicine is commonly used alongside modern healthcare practices. An herbal remedy derived from the roots of a weed, which was traditionally used to alleviate malarial symptoms, was combined with leaves and aerial portions from two other plants with antimalarial activity, formulated as a tea, and eventually licensed and sold as an antimalarial phytomedicine.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 14-Apr-2015
Journal of Psychiatric Research
Wristband that measures rest, activity schedule may help predict response to antidepressants
A wristband that records motion throughout a 24-hour cycle may be an inexpensive, safe way to determine which patients with major depressive disorder will respond best to commonly prescribed drugs such as Prozac.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 14-Apr-2015
PLOS Medicine
How best to test Ebola treatment
An unconventional clinical trial design might have advantages over classical trials for testing treatments for Ebola virus disease (EVD), suggests a study published this week in PLOS Medicine. The work of an international team led by John Whitehead of Lancaster University, UK and Ben Cooper of Oxford University, UK, provides much-needed data to inform a debate on the scientific and ethical justification for non-randomized EVD trials.
Wellcome Trust, European Union, Medical Research Council, Department for International Development

Contact: Hugh O' Brien

Public Release: 13-Apr-2015
Health Affairs
The cost and quality of cancer care in Health Affairs' April issue
The April issue of Health Affairs contains a cluster of papers focusing on the cost and quality of cancer care. Other subjects covered in the issue: health care payment reform and the diminished number of uninsured young adults. Publication of the cancer studies in the April issue was supported by Precision Health Economics and the Celgene Corporation.

Contact: Sue Ducat
Health Affairs

Public Release: 13-Apr-2015
NIH, South African Medical Research Council award $8 million in HIV, TB grants
NIH and the South African Medical Research Council are awarding 31 grants to US and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa-US Program for Collaborative Biomedical Research.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Kathy Stover
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Apr-2015
Cell Reports
New Ebola study points to potential drug target
Opening the door to potential treatments for the deadly Ebola virus, scientists led by Washington University School of Medicine in St. Louis have shown that interfering with its replication can stop the virus in its tracks.
US Department of Defense, National Institutes of Health

Contact: Diane Duke Williams
Washington University School of Medicine

Showing releases 801-825 out of 1284.

<< < 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>